1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Exosomes Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Non-coding RNAs
  • 1.2.3 Lipids
  • 1.2.4 mRNA
  • 1.2.5 DNA fragments
  • 1.2.6 Proteins /peptides
• 1.3 Market by Application
  • 1.3.1 Global Exosomes Market Share by Application: 2020 VS 2026
  • 1.3.2 Cancer
  • 1.3.3 Infectious diseases
  • 1.3.4 Neurodegenerative diseases
  • 1.3.5 Cardiovascular diseases
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Exosomes Market Perspective (2015-2026)
• 2.2 Global Exosomes Growth Trends by Regions
  • 2.2.1 Exosomes Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Exosomes Historic Market Share by Regions (2015-2020)
  • 2.2.3 Exosomes Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Exosomes Players by Market Size
  • 3.1.1 Global Top Exosomes Players by Revenue (2015-2020)
  • 3.1.2 Global Exosomes Revenue Market Share by Players (2015-2020)
• 3.2 Global Exosomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Exosomes Revenue
• 3.4 Global Exosomes Market Concentration Ratio
  • 3.4.1 Global Exosomes Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Exosomes Revenue in 2019
• 3.5 Key Players Exosomes Area Served
• 3.6 Key Players Exosomes Product Solution and Service
• 3.7 Date of Enter into Exosomes Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Exosomes Breakdown Data by Type (2015-2026)

• 4.1 Global Exosomes Historic Market Size by Type (2015-2020)
• 4.2 Global Exosomes Forecasted Market Size by Type (2021-2026)

5 Exosomes Breakdown Data by Application (2015-2026)

• 5.1 Global Exosomes Historic Market Size by Application (2015-2020)
• 5.2 Global Exosomes Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Exosomes Market Size (2015-2026)
• 6.2 North America Exosomes Market Size by Type (2015-2020)
• 6.3 North America Exosomes Market Size by Application (2015-2020)
• 6.4 North America Exosomes Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Exosomes Market Size (2015-2026)
• 7.2 Europe Exosomes Market Size by Type (2015-2020)
• 7.3 Europe Exosomes Market Size by Application (2015-2020)
• 7.4 Europe Exosomes Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Exosomes Market Size (2015-2026)
• 8.2 China Exosomes Market Size by Type (2015-2020)
• 8.3 China Exosomes Market Size by Application (2015-2020)
• 8.4 China Exosomes Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Exosomes Market Size (2015-2026)
• 9.2 Japan Exosomes Market Size by Type (2015-2020)
• 9.3 Japan Exosomes Market Size by Application (2015-2020)
• 9.4 Japan Exosomes Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Exosomes Market Size (2015-2026)
• 10.2 Southeast Asia Exosomes Market Size by Type (2015-2020)
• 10.3 Southeast Asia Exosomes Market Size by Application (2015-2020)
• 10.4 Southeast Asia Exosomes Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Fujifilm
  • 11.1.1 Fujifilm Company Details
  • 11.1.2 Fujifilm Business Overview
  • 11.1.3 Fujifilm Exosomes Introduction
  • 11.1.4 Fujifilm Revenue in Exosomes Business (2015-2020))
  • 11.1.5 Fujifilm Recent Development
• 11.2 Thermo Fisher Scientific
  • 11.2.1 Thermo Fisher Scientific Company Details
  • 11.2.2 Thermo Fisher Scientific Business Overview
  • 11.2.3 Thermo Fisher Scientific Exosomes Introduction
  • 11.2.4 Thermo Fisher Scientific Revenue in Exosomes Business (2015-2020)
  • 11.2.5 Thermo Fisher Scientific Recent Development
• 11.3 Danaher
  • 11.3.1 Danaher Company Details
  • 11.3.2 Danaher Business Overview
  • 11.3.3 Danaher Exosomes Introduction
  • 11.3.4 Danaher Revenue in Exosomes Business (2015-2020)
  • 11.3.5 Danaher Recent Development
• 11.4 Illumina
  • 11.4.1 Illumina Company Details
  • 11.4.2 Illumina Business Overview
  • 11.4.3 Illumina Exosomes Introduction
  • 11.4.4 Illumina Revenue in Exosomes Business (2015-2020)
  • 11.4.5 Illumina Recent Development
• 11.5 Qiagen
  • 11.5.1 Qiagen Company Details
  • 11.5.2 Qiagen Business Overview
  • 11.5.3 Qiagen Exosomes Introduction
  • 11.5.4 Qiagen Revenue in Exosomes Business (2015-2020)
  • 11.5.5 Qiagen Recent Development
• 11.6 Takara Bio
  • 11.6.1 Takara Bio Company Details
  • 11.6.2 Takara Bio Business Overview
  • 11.6.3 Takara Bio Exosomes Introduction
  • 11.6.4 Takara Bio Revenue in Exosomes Business (2015-2020)
  • 11.6.5 Takara Bio Recent Development
• 11.7 Malvern Instruments
  • 11.7.1 Malvern Instruments Company Details
  • 11.7.2 Malvern Instruments Business Overview
  • 11.7.3 Malvern Instruments Exosomes Introduction
  • 11.7.4 Malvern Instruments Revenue in Exosomes Business (2015-2020)
  • 11.7.5 Malvern Instruments Recent Development
• 11.8 Miltenyi Biotec
  • 11.8.1 Miltenyi Biotec Company Details
  • 11.8.2 Miltenyi Biotec Business Overview
  • 11.8.3 Miltenyi Biotec Exosomes Introduction
  • 11.8.4 Miltenyi Biotec Revenue in Exosomes Business (2015-2020)
  • 11.8.5 Miltenyi Biotec Recent Development
• 11.9 MBL International
  • 11.9.1 MBL International Company Details
  • 11.9.2 MBL International Business Overview
  • 11.9.3 MBL International Exosomes Introduction
  • 11.9.4 MBL International Revenue in Exosomes Business (2015-2020)
  • 11.9.5 MBL International Recent Development
• 11.10 Lonza
  • 11.10.1 Lonza Company Details
  • 11.10.2 Lonza Business Overview
  • 11.10.3 Lonza Exosomes Introduction
  • 11.10.4 Lonza Revenue in Exosomes Business (2015-2020)
  • 11.10.5 Lonza Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Exosomes Scope and Market Size
Exosomes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Exosomes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Non-coding RNAs
Lipids
mRNA
DNA fragments
Proteins /peptides

Market segment by Application, split into
Cancer
Infectious diseases
Neurodegenerative diseases
Cardiovascular diseases

Based on regional and country-level analysis, the Exosomes market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Exosomes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Fujifilm
Thermo Fisher Scientific
Danaher
Illumina
Qiagen
Takara Bio
Malvern Instruments
Miltenyi Biotec
MBL International
Lonza